by Greg Kuehn | Sep 5, 2019 | Press Releases
CARLSBAD, Calif., Sept. 4, 2019 /PRNewswire/ — Prescient Metabiomics, a privately held company and a subsidiary of Prescient Medicine Holdings, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted the company’s submission...
by Greg Kuehn | Sep 18, 2018 | Press Releases
Innovative new microbiome GI health solutions battle colon cancer and gastrointestinal disease Chicago, Sept. 18, 2018 – Prescient Medicine Holdings, LLC and Metabiomics Corp., have announced a joint venture to develop an innovative microbiome diagnostics platform for...
by Greg Kuehn | Dec 16, 2015 | Press Releases
PRESS RELEASE Cambridge, UK and Aurora, CO December 16, 2015 Metabiomics Corp. announced it has secured a distribution agreement with Origin Sciences pursuant to which it will develop, test, and commercialize the novel OriCol™ gastrointestinal sampling technology for...
